AIFF
Firefly Neuroscience, Inc. (AIFF) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Technology sector peers. Its strongest pillar is Growth (B+); its weakest is Momentum (C-). The rating has held at C+ for 2 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | C+ (2.8) | B+ (3.6) | C (2.3) | C- (1.9) | C+ (2.6) | C+ (2.7) |
| 2026-11-10 | C+ (2.8) | A- (3.9) | C+ (2.7) | C- (2.1) | C+ (2.6) | C+ (2.8) |
| 2026-11-03 | C+ (2.8) | A- (3.9) | C+ (2.8) | C- (2.0) | C+ (2.6) | C+ (2.8) |
| 2026-10-27 | C+ (2.8) | A- (4.0) | C+ (2.8) | C (2.5) | C+ (2.5) | B- (2.9) |
| 2026-10-20 | C+ (2.8) | A- (3.9) | C+ (2.8) | D+ (1.8) | C+ (2.5) | C+ (2.8) |